Computed tomography is more sensitive than CA 125 in detecting disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial

Category Primary study
JournalEuropean Journal of Cancer
Year 2015
This article has no abstract
Epistemonikos ID: d23529f59fbd504d662170b91afba007cbb625e6
First added on: Feb 07, 2025